Excelsior Biopharma

Excelsior Biopharma EBIT Margin

The EBIT Margin (Operating Margin) of Excelsior Biopharma (6496.TWO) as of Oct 28, 2026 is -19.39 %. In the previous year, EBIT Margin (Operating Margin) was -9.61 % — a change of 101.85% (lower).

EBIT Margin

-19.39 %

YoY

101.85%

Last updated:

EBIT Margin (Operating Margin) of Excelsior Biopharma is 2025 -19.39 % . EBIT Margin (Operating Margin) of Excelsior Biopharma was 2024 -9.61 % . It decreases by 101.85% lower compared to the previous year.

For Excelsior Biopharma, the operating (EBIT) margin of -19.4% is down versus -0.1% a few years ago.

The Excelsior Biopharma EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
16.70 TWD
Jan 1, 2019
5.63 TWD
Jan 1, 2020
3.24 TWD
Jan 1, 2021
-0.08 TWD
Jan 1, 2022
-3.84 TWD
Jan 1, 2023
-10.48 TWD
Jan 1, 2024
-9.61 TWD
Jan 1, 2025
-19.39 TWD
The Excelsior Biopharma EBIT Margin history
YEAREBIT MarginYoY
-19.39 %+101.85%
-9.61 %-8.31%
-10.48 %+172.58%
-3.84 %+4,947.76%
-0.08 %-102.35%
3.24 %-42.49%
5.63 %-66.26%
16.70 %-12.06%
18.99 %+35.27%
14.04 %-0.74%
14.14 %-17.21%
17.08 %+9,120.14%
0.19 %-26.51%
0.25 %-6.14%
0.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Excelsior Biopharma Stock analysis

What does Excelsior Biopharma do? Excelsior Biopharma Inc., headquartered in Taipei City, Taiwan, operates in the Health Care sector. The company focuses on the research, development, manufacturing, and distribution of pharmaceutical products, including prescription and non-prescription drugs, health care products, medical equipment, and rapid test reagents. Listed on 19 December 2014, Excelsior Biopharma serves both domestic and international markets with its diverse product portfolio. Excelsior Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Excelsior Biopharma stock

EBIT Margin (Operating Margin) of Excelsior Biopharma is -19.39 % in 2025.

EBIT Margin (Operating Margin) of Excelsior Biopharma changed from -9.61 % to -19.39 %, representing a 101.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Excelsior Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Excelsior Biopharma with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Excelsior Biopharma

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Excelsior Biopharma